We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Australia to Host Conference on Lab Technology

By HospiMedica staff writers
Posted on 14 Mar 2006
A conference on emergency laboratory technology and the changing clinical laboratory environment will take place in Cairns (Queensland, Australia) on May 29-30, 2006. More...
The meeting, called "Laboratory Medicine in the Future: Planning for Tomorrow's Technology,” is being organized by the AACB (Australasian Association of Clinical Biochemists), the AACC (American Association for Clinical Chemistry), the APFCB (Asian Pacific Federation of Clinical Biochemistry), and the IFCC (International Federation of Clinical Chemistry).

Experts from around the world will give practical advice on how to adapt to the "omics” revolution, emerging markers, trends in the workforce and patient populations, patient safety initiatives, information technology (IT) innovations, testing growth areas, new infectious diseases, and pandemics. Industry leaders will discuss the most significant changes that are being introduced to the clinical laboratory and its field.

Special panels will explore the coming IT innovations and how they help to improve patient outcomes. The key speakers include a U.S. Food and Drug Administration (FDA) representative who will explain how the agency will regulate new technologies and the move to global standardization.

The program is designed for laboratory leaders, directors and managers worldwide, diagnostics representatives, laboratory consultants, and all health care professionals who will be affected by coming changes in the clinical laboratory. The conference manual will be a guide for future trends in laboratory medicine and is full of practical information. Emerging technologies will have an important role in the future of laboratory medicine by shaping how tests are performed and managed.



Related Links:
Australasian Association of Clinical Biochemists
American Association for Clinical Chemistry
International Federation of Clinical Chemistry

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.